Middle East & Africa Cannabidiol (CBD) Market, By Source (Hemp And Marijuana), Grade (Food Grade And Therapeutics Grade), Nature (Organic And Inorganic), Application (Tincture, Food, Beverages, Pharmaceutical, Topical, Dietary Supplements And Others), Product Type (CBD Oil, CBD Concentrates, CBD Isolates And Others) - Industry Trends and Forecast to 2029.
Middle East and Africa Cannabidiol (CBD) Market Analysis and Insights
Middle East & Africa cannabidiol (CBD) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 22.7% in the forecast period of 2022 to 2029. Technological advancements in cannabidiol (CBD) drug treatments, rise in the healthcare sector are another factors drive growth of the Middle East & Africa cannabidiol (CBD) market in the forecast period.
However, side effects associated with CBD oil and counterfeit and synthetic products available in the market will restraining the market growth. Adoption of strategic alliances like partnerships and acquisitions by key market players act as an opportunity for the growth of Middle East & Africa cannabidiol (CBD) market.
Report Metric |
Details |
Forecast Period |
2022 to 2029 |
Base Year |
2021 |
Historic Years |
2020 (Customizable to 2019-2014) |
Quantitative Units |
Revenue in USD Million, Pricing in USD |
Segments Covered |
By Source (Hemp And Marijuana), Grade (Food Grade And Therapeutics Grade), Nature (Organic And Inorganic), Application (Tincture, Food, Beverages, Pharmaceutical, Topicals, Dietary Supplements And Others), Product Type (CBD Oil, CBD Concentrates, CBD Isolates And Others) |
Countries Covered |
U.A.E, Israel, South Africa and rest of the Middle East |
Market Players Covered |
Some of the key players operating in the Middle East & Africa cannabidiol (CBD) market are CV Sciences, Inc., VIVO Cannabis Inc., Gaia Herbs Hemp, Phoena Holdings Inc., Medical Marijuana, Inc., The Cronos Group, CHARLOTTE’S WEB, HEXO Corp., Aurora Cannabis, Canopy Growth Corporation, Jazz Pharmaceuticals, Inc., Tilray, Curaleaf, KAZMIRA, Freedom Leaf, Inc., Koi CBD, Groff North America Hemplex, Joy Organics, Elixinol Wellness Limited, Isodiol International Inc., Healthy Food Ingredients, LLC, NuLeaf Naturals, LLC, Diamond CBD, Medterra CBD, ENDOCA, Green Roads among others. |
Cannabidiol (CBD) Market Definition
Cannabidiol (CBD) is a chemical compound that is found in the cannabis sativa plant, and is extracted from hemp or cannabis, generally from hemp due to its naturally high cannabidiol (CBD) content. It has several benefits in treating anxiety and seizures and reducing pain. Due to its healing properties, the demand for CBD for health and wellness purposes is high, which is the major factor driving the market. Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the Middle East & Africa market is anticipated to grow at a lucrative rate over the forecast period. Cannabidiol oil is increasingly being used to make skincare products to treat acne and wrinkles. Sephora, for example, had recently introduced cannabidiol or CBD skincare line to its stores. Similarly, Ulta Beauty is intending to launch a cannabidiol-based product line. Several new companies are also entering the market for cannabidiol-infused cosmetic products.
Furthermore, the government of different countries as well as major players in the cannabinoid market are investing in research and development activities. The CBD is said to be an effective treatment for various neurological diseases including epilepsy in several clinical trials.
Market Dynamics
Drivers
- Increasing demand for CBD in health & fitness
Rising awareness among consumers regarding health and fitness will help CBD market to witness rapid growth. Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in this sector.
Moreover, CBD products are used to relieve various problems such as anxiety/ stress, sleep/insomnia, chronic pain, migraine, skin care, seizures, joint pain & inflammation, neurological conditions, and many others. The chronic pain treatment has gained much popularity due to additional benefits offered by CBD when used. There has been increasing demand for cannabidiol (CBD) products over recent years owing to its widespread medical applications and pain relief treatment. CBD helps in reducing chronic pain by acting on variety of biological process in the body. In addition, CBD possesses antioxidant, anti-inflammatory and analgesic properties. Therefore, CBD products reduces the anxiety that is experienced by the people suffering from the chronic pain. Thus, the increasing demand for CBD in the treatment of chronic pain is augmenting the market to grow. This also help people to maintain their health and fitness routines, while staying away from pain that may occur during fitness activities.
- Improving government approvals and regulations for CBD products
There are strict government regulations and CBD based products required strict approvals before they were marketed and supplied in the local as well international market, which limited the growth of the market. However, with time these restrictions have been eased up and there has been increasing acceptance of refined CBD products combined with the increasing legalization of marijuana and marijuana-derived products for various applications. This will drive the growth and demand in the market.
Moreover, there is the presence of major manufacturers of CBD products across the globe which has further induced the government and other regulatory bodies such as Food and Drug Administration (F.D.A.) in the U.S., European Union in Europe, etc. to ease up the restrictions for CBD and CBD based products.
Restraint
-
High cost of CBD products
CBD is a popular and a holistic choice for people struggling with pain, inflammation, and sleep problems. Since CBD is a new product with less research and development and has lately been regulated and approved, therefore, the price of CBD are subject to fluctuations. The production of hemp became legal in 2018, which affected the price of CBD products. As a result, various CBD products witnessed some price inflation.
Moreover, many farmers are transitioning towards growing and selling hemp used to make CBD products, but despite the increased popularity of this product, it presents its own agricultural challenges. Firstly, switching over to a new crop results in new expenses. The most efficient way to harvest hemp is using a combine harvester. However, farmers who have previously grown crops that don’t require combines, such as strawberries, can’t afford to purchase a combine right away. Therefore, they need to hire people to help harvest the hemp, which drives up overall product prices as the raw material becomes costly.
Additionally, hemp requires more time and labor to grow and farmers need to inspect their crop closely as it grows. Furthermore, once it is harvested, extracting the cannabidiol is a difficult and expensive process. The processors and extractors of CBD need to use either ethanol or supercritical carbon dioxide (CO2 extraction). The extraction and refinement process requires special machinery and takes a long time, which drives up the CBD cost. Thus, all these factors add up to the costs of CBD products making them much more costly than other products, which is likely to restrain the market’s demand.
Opportunity
-
Increasing investments in development of new CBD based products
With the increasing trend of providing innovative and refined products in the market, manufacturers are spending large amounts in research and development for the production of new CBD based products. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand.
The increasing demand has increased the number of trials to study the impact of CBD on certain health conditions, which is expected to develop new products in turn providing opportunity for the rise in the demand in the forthcoming years. Furthermore, many companies procure CBD oils in bulk and manufacture CBD-infused products. In addition, numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance.
Moreover, with the ease in regulations and post the approval of cannabis products, the companies are investing huge amounts in the product development and upgrading the raw material production, which will also help them to cut down on costs while meeting the surging demand in the market. The new product development and increasing research and development activities along with various strategic decisions taken by key manufacturers in the market will offer lucrative opportunity for the growth of the Middle East & Africa CBD market.
Challenge
- Side effects associated with CBD oil
Cannabidiol is well-known for its ability to cure a variety of illnesses, including anxiety, seizures, neurological problems, cancer-related nausea, chronic pain, and more. However, being useful for a variety of medical illnesses, various studies and research conducted by numerous organizations have shown that CBD-based medicines can have negative effects as well.
Some of the side effects that are commonly experienced by consumers include dry mouth, drowsiness, low blood pressure, and lightheadedness. CBD is also known to raise the level of Coumadin (a blood thinner) in the body, which can interact with other drugs and cause negative side effects. These factors might impede future adoption of CBD for therapeutic purposes.
Moreover, another cause for concern is the unreliability of the purity and dosage of CBD in products such as CBD oil. High concentration of CBD oil can also have harmful effects on the consumers’ health. In some cases, excessive use of CBD oil may also increase liver enzymes, which is a marker of liver inflammation. Cytochrome P450 (CYP450) is an enzyme which body uses to break down some drugs. CBD oil can block CYP450. That means that taking CBD oil with these drugs could make them have a stronger effect than one needs or make them not work at all.
Further, dietary supplements that contain CBD and a blend of herbal ingredients may not be safe for everyone, as many herbs have the potential to interact with commonly prescribed medications. All these side effects may vary from person to person as minor side effects for some may prove to be serious for others. This may pose as a challenge for the increasing demand of CBD products in the Middle East & Africa CBD market.
Post COVID-19 Impact on Middle East & Africa cannabidiol (CBD) market
COVID-19 has resulted in a substantial upsurge in demand for medical supplies from both healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment on the market. COVID-19 is anticipated to have a big impact on the Middle East & Africa cannabidiol (CBD) market.
Middle East & Africa cannabidiol (CBD) market Scope and Market Size
Middle East & Africa cannabidiol (CBD) market is segmented on the basis source, grade, application, product type, nature. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the Difference in your target markets.
BY SOURCE
- HEMP
- MARIJUANA
On the basis of source, the Middle East & Africa cannabidiol (CBD) market is segmented into hemp and marijuana.
BY PRODUCT TYPE
- CBD OIL
- CBD ISOLATES
- CBD CONCENTRATES
- OTHERS
On the basis of product type, the Middle East & Africa cannabidiol (CBD) market is segmented into CBD oil, CBD concentrates, CBD isolates and others
BY NATURE
- ORGANIC
- INORGANIC
On the basis of nature, the Middle East & Africa cannabidiol (CBD) market is segmented into organic and inorganic.
BY GRADE
- FOOD GRADE
- THERAPEUTIC GRADE
On the basis of grade, the Middle East & Africa cannabidiol (CBD) market is segmented into food grade and therapeutics grade.
BY APPLICATION
- Tincture
- Food
- Beverages
- Pharmaceutical
- Topicals
- Dietary supplements
- Others
On the basis of application, the Middle East & Africa cannabidiol (CBD) market is segmented into tincture, food, beverages, pharmaceutical, topicals, dietary supplements and others.
Middle East & Africa cannabidiol (CBD) market Country Level Analysis
The cannabidiol (CBD) market is analyzed and market size information is provided by source, grade, application, product type, nature.
The countries covered in the cannabidiol (CBD) market report are U.A.E, Israel, South Africa and rest of the Middle East.
In 2022, South Africa is dominating due to the presence of key market players along the largest consumer market with high GDP. South Africa is expected to grow due to rise in technological advancement in drug treatments.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East & Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Cannabidiol (CBD) market also provides you with detailed market analysis for every country growth in healthcare industry. Moreover, it provides detailed information regarding healthcare services and treatments, impact of regulatory scenarios, and trending parameters regarding cannabidiol (CBD) market.
Competitive Landscape and Middle East & Africa Cannabidiol (CBD) Market Share Analysis
Middle East & Africa cannabidiol (CBD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cannabidiol (CBD) products.
The major companies which are dealing in the cannabidiol (CBD) market are CV Sciences, Inc., VIVO Cannabis Inc., Gaia Herbs Hemp, Phoena Holdings Inc., Medical Marijuana, Inc., The Cronos Group, CHARLOTTE’S WEB, HEXO Corp., Aurora Cannabis, Canopy Growth Corporation, Jazz Pharmaceuticals, Inc., Tilray, Curaleaf, KAZMIRA, Freedom Leaf, Inc., Koi CBD, Groff North America Hemplex, Joy Organics, Elixinol Wellness Limited, Isodiol International Inc., Healthy Food Ingredients, LLC, NuLeaf Naturals, LLC, Diamond CBD, Medterra CBD, ENDOCA, Green Roads among others.
Strategic alliances like mergers, acquisitions and agreement by the key market players are further expected to accelerate the growth of cannabidiol (CBD) products.
For instance,
- In May, 2022, Canopy Growth Corporation and Lemurian, Inc., a California-based producer of high-quality cannabis extracts and pioneer of clean vape technology, announced that they have entered into definitive agreements providing Canopy Growth, by way of a wholly-owned subsidiary, the right to acquire, upon federal permissibility of THC in the U.S. or earlier at Canopy Growth’s election, up to 100% of the outstanding capital stock of Jetty.This has helped the company to expand their business in market.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 BENCHMARKING ANALYSIS
4.2 CBD PRODUCTS, INCLUDING CANNABINOIDS (IN %)
4.3 CBD RAW MATERIAL DEVELOPMENT TREND
4.3.1 MORE CONTROLLED CBD LEVELS:
4.3.2 CBD AND GENETICS:
4.3.3 ADVANCEMENTS MADE IN EXTRACTION:
4.3.4 NANOTECHNOLOGY
4.3.5 CONCLUSION
4.4 COMPANY POSITIONING GRID
4.4.1 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: COMPANY LANDSCAPE
4.4.1.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
4.4.1.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
4.4.1.3 COMPANY SHARE ANALYSIS: EUROPE
4.4.1.4 COMPANY SHARE ANALYSIS: SOUTH AMERICA
4.4.2 COMPANY’S CURRENT VENDORS
4.5 OVERALL VOLUME (KILO TONS) & QUANTITY OF COMPLETED TRANSACTIONS: MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET
4.6 LIST OF COUNTRIES THAT LEGALIZED CANNABIDIOL (CBD)
4.7 REGULATION COVERAGE
4.8 IMPORT & EXPORT REGULATION
4.8.1 IMPORT REGULATIONS
4.8.2 EXPORT REGULATIONS
4.9 IMPORT STANDARDS
4.1 GOVERNMENT POLICIES
4.11 QUALIFICATION/CERTIFICATION REQUIRED
4.12 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: PRICING ANALYSIS & DEAL PRICING
4.13 RAW MATERIAL EXTRACTOR POSITIONING GRID
4.13.1 KEY EXTRACTION
4.13.2 LINE CAPABILITY
4.14 TECHNOLOGICAL ADVANCEMENTS:
4.15 VENDOR/ DISTRIBUTOR SHARE ANALYSIS
4.16 VENDOR/DISTRIBUTOR KEY BUYERS
5 CLIMATE CHANGE SCENARIO: MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET
5.1 ENVIRONMENT CONCERNS-
5.2 INDUSTRY RESPONSE-
5.3 GOVERNMENT INITIATIVES
5.4 ANALYST RECOMMENDATIONS
6 SUPPLY CHAIN OF THE MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET
6.1 LOGISTIC COST SCENARIO
6.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN DEMAND FOR CBD IN HEALTH & FITNESS
7.1.2 IMPROVING GOVERNMENT APPROVALS AND REGULATIONS FOR CBD PRODUCTS
7.1.3 THERAPEUTIC PROPERTIES OF CBD OIL
7.1.4 CONSUMERS' SHIFT TOWARDS LEGALLY PURCHASING CANNABIS FOR MEDICAL AS WELL AS RECREATIONAL USE
7.2 RESTRAINTS
7.2.1 HIGH COST OF CBD PRODUCTS
7.2.2 AVAILABILITY OF COUNTERFEIT AND SYNTHETIC PRODUCTS IN THE MARKET
7.3 OPPORTUNITIES
7.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF NEW CBD BASED PRODUCTS
7.3.2 GROWING MEDICAL APPLICATIONS OF CBD
7.4 CHALLENGES
7.4.1 SIDE EFFECTS ASSOCIATED WITH CBD OIL
7.4.2 BARRIERS IN TERMS OF MARKETING OF CBD
8 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY SOURCE
8.1 OVERVIEW
8.2 HEMP
8.3 MARIJUANA
9 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 CANNABIDIOL (CBD) OIL
9.2.1 CARBON DIOXIDE EXTRACTION
9.2.2 STEAM DISTILLATION
9.2.3 SOLVENT EXTRACTION
9.2.4 OTHERS
9.3 CANNABIDIOL (CBD) ISOLATES
9.4 CANNABIDIOL (CBD) CONCENTRATES
9.5 OTHERS
10 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY NATURE
10.1 OVERVIEW
10.2 ORGANIC
10.3 INORGANIC
11 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY GRADE
11.1 OVERVIEW
11.2 FOOD GRADE
11.3 THERAPEUTIC GRADE
12 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 TINCTURE
12.3 FOOD
12.3.1 CHOCOLATE & CONFECTIONERY
12.3.1.1 CANDY
12.3.1.2 CHOCOLATE
12.3.1.3 CHEWS
12.3.1.4 GUMMIES
12.3.1.5 OTHERS
12.3.2 HONEY
12.3.3 DAIRY BASED EDIBLE
12.3.3.1 MILK
12.3.3.2 ICE CREAM
12.3.3.3 OTHERS
12.3.4 SAUCES AND SEASONINGS
12.3.5 BAKERY EDIBLE
12.3.5.1 COOKIES AND BISCUITS
12.3.5.2 BROWNIES
12.3.5.3 OTHERS
12.3.6 OTHERS
12.3.7 PHARMACEUTICALS
12.3.7.1 DRAVET SYNDROME
12.3.7.2 MULTIPLE SCLEROSIS DRUG APPLICATIONS
12.3.7.3 NEUROLOGICAL DRUG APPLICATIONS
12.3.7.4 CANCER DRUG APPLICATIONS
12.3.7.5 OTHERS
12.3.8 DIETARY SUPPLEMENTS
12.3.8.1 CAPSULES
12.3.8.2 GUMMIES
12.3.8.3 OTHERS
12.3.9 BEVERAGES
12.3.9.1 NON-ALCOHOLIC BEVERAGES
12.3.9.1.1 ENERGY DRINKS
12.3.9.1.2 SOFT DRINKS
12.3.9.1.3 RTD COFFEE
12.3.9.1.4 TEA
12.3.9.1.5 SPARKLING WATER
12.3.9.1.6 OTHERS
12.3.9.2 FLAVORED DRINKS
12.3.9.2.1 ORANGE
12.3.9.2.2 LEMON
12.3.9.2.3 BERRIES
12.3.9.2.4 COCONUT
12.3.9.2.5 OTHERS
12.3.9.3 ALCOHOLIC BEVERAGES
12.3.9.3.1 BEER
12.3.9.3.2 WINE
12.3.9.3.3 OTHERS
12.3.9.4 OTHERS
12.3.10 TOPICAL
12.3.10.1 LOTION
12.3.10.2 SALVE
12.3.10.3 LIP BALM
12.3.10.4 OTHERS
12.3.11 OTHERS
12.3.11.1 VAPES
12.3.11.2 CIGARETTES
12.3.11.3 SPA AND RECREATION
13 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 U.A.E
13.1.3 ISRAEL
13.1.4 REST OF MIDDLE EAST AND AFRICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 CURALEAF
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 TILRAY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 JAZZ PHARMACEUTICALS, INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 CANOPY GROWTH CORPORATION
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 AURORA CANNABIS.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 CHARLOTTE’S WEB.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 CV SCIENCES, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 DIAMOND CBD.
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 ELIXINOL WELLNESS LIMITED
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 ENDOCA.
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 FREEDOM LEAF, INC
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 GAIA HERBS HEMP
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 GREEN ROADS.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 GROFF NORTH AMERICA HEMPLEX
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 HEXO CORP.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 HEALTHY FOOD INGREDIENTS, LLC.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 ISODIOL INTERNATIONAL INC
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 JOY ORGANICS
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 KAZMIRA
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 KOI CBD
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 MEDICAL MARIJUANA, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 EVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 MEDTERRA CBD
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 NULEAF NATURALS, LLC
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 PHOENA HOLDINGS INC.
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 THE CRONOS GROUP
15.25.1 COMPANY SNAPSHOT
15.25.2 REVENUE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENTS
15.26 VIVO CANNABIS INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 REVENUE ANALYSIS
15.26.3 PRODUCT PORTFOLIO
15.26.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 BENCHMARK ANALYSIS
TABLE 2 AVERAGE VOLUME TREND FOR MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET (KILO TONS)
TABLE 3 THE FOLLOWING ARE THE PRICES OF PRODUCTS OFFERED BY THE COMPANIES:
TABLE 4 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA HEMP IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA MARIJUANA IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) ISOLATES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) CONCETRATES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA ORGANIC IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA INORGANIC IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA FOOD GRADE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA THERAPEUTIC GRADE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA TINCTURE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA FOOD IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA FOOD IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA PHARMACEUTICALS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA TOPICAL IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA TOPICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA TOPICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 SOUTH AFRICA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 59 SOUTH AFRICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 60 SOUTH AFRICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 61 SOUTH AFRICA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 62 SOUTH AFRICA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 63 SOUTH AFRICA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 SOUTH AFRICA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 65 SOUTH AFRICA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 66 SOUTH AFRICA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 67 SOUTH AFRICA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 SOUTH AFRICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 SOUTH AFRICA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 70 SOUTH AFRICA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 71 SOUTH AFRICA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 72 SOUTH AFRICA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 73 SOUTH AFRICA TOPICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 74 SOUTH AFRICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 75 SOUTH AFRICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 76 U.A.E CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 77 U.A.E CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 78 U.A.E CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 79 U.A.E CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 80 U.A.E CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 81 U.A.E CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 82 U.A.E FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 83 U.A.E CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 84 U.A.E BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 85 U.A.E DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 86 U.A.E BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 87 U.A.E ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 88 U.A.E NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 89 U.A.E FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 90 U.A.E PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 91 U.A.E TOPICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 92 U.A.E DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 93 U.A.E OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 94 ISRAEL CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 95 ISRAEL CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 96 ISRAEL CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 97 ISRAEL CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 98 ISRAEL CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 99 ISRAEL CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 100 ISRAEL FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 101 ISRAEL CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 102 ISRAEL BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 ISRAEL DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 ISRAEL BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 105 ISRAEL ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 106 ISRAEL NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 107 ISRAEL FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 108 ISRAEL PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 ISRAEL TOPICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 110 ISRAEL DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 111 ISRAEL OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 112 REST OF MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 THE INCREASING DEMAND FOR CANNABIDIOL (CBD) DUE TO ITS HEALING PROPERTIES AND HEALTH AND WELLNESS PURPOSES IS HIGH, WHICH IS THE MAJOR FACTOR DRIVING THE MARKET IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 HEMP IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET IN 2022 & 2029
FIGURE 13 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 14 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 15 EUROPE CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 16 SOUTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 17 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: VENDOR/ DISTRIBUTOR SHARE ANALYSIS (%)
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET
FIGURE 19 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY SOURCE, 2021
FIGURE 20 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY SOURCE, 2022-2029 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY SOURCE, CAGR (2022-2029)
FIGURE 22 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, 2021
FIGURE 24 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 26 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY NATURE, 2021
FIGURE 28 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY NATURE, 2022-2029 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY NATURE, CAGR (2022-2029)
FIGURE 30 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY NATURE, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY GRADE, 2021
FIGURE 32 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY GRADE, 2022-2029 (USD MILLION)
FIGURE 33 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY GRADE, CAGR (2022-2029)
FIGURE 34 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY GRADE, LIFELINE CURVE
FIGURE 35 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, 2021
FIGURE 36 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 37 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 38 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 39 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET: SNAPSHOT (2021)
FIGURE 40 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2021)
FIGURE 41 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MARKET: BY SOURCE (2022-2029)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.